These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37104212)

  • 1. Botulinum Toxin Type A for the Treatment of Auriculotemporal Neuralgia-A Case Series.
    Tereshko Y; Belgrado E; Lettieri C; Gigli GL; Valente M
    Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin as a novel therapeutic approach for auriculotemporal neuralgia.
    Pinto MJ; Guerrero AL; Costa A
    Headache; 2021 Feb; 61(2):392-395. PubMed ID: 33433917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin - neuropathic pain: Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE; Smith A; Hawkins JM
    Clin Neuropharmacol; 2020; 43(5):162-163. PubMed ID: 32947428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
    Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E; Sadoughi B; Blitzer A; Sirois D
    Laryngoscope; 2014 Feb; 124(2):413-7. PubMed ID: 23818108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity.
    De Icco R; Perrotta A; Berra E; Allena M; Alfonsi E; Tamburin S; Serrao M; Sandrini G; Tassorelli C
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31226803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
    Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
    J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
    Han ZA; Song DH; Chung ME
    Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
    Luvisetto S; Gazerani P; Cianchetti C; Pavone F
    Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
    Trials; 2015 Dec; 16():550. PubMed ID: 26634453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
    Mahowald ML; Singh JA; Dykstra D
    Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uses of botulinum toxin.
    Girdler NM
    Lancet; 1997 Mar; 349(9056):953. PubMed ID: 9093271
    [No Abstract]   [Full Text] [Related]  

  • 20. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm.
    Johnstone SJ; Adler CH
    Headache; 1998 May; 38(5):366-8. PubMed ID: 9630789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.